Chronic lymphocytic leukemia (CLL), the most common leukemia diagnosed in adults from Western countries, is characterized by a monoclonal population of mature activated B lymphocytes that usually express CD5+ and CD23+. This evidence concerns the gene FCER2 and B-cell chronic lymphocytic leukemia.